Historical source coverage

2022

223 selected records with a cited source date in 2022, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2022 by record type

4 types

December 2022

25 records on this page

Literature metadata · Pasireotide

Second line treatment of acromegaly: Pasireotide or Pegvisomant?

PubMed lists PMID 35931640 in Best practice & research. Clinical endocrinology & metabolism as Meta-Analysis, Journal Article, Review, with publication-date metadata of 2022-07-16 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01439997

PeptideScanner retained ClinicalTrials.gov record NCT01439997 at 2026-11-16T01:33:21.554Z. Its registry update date was 2022-12-15, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Mecasermin

Mecasermin for primary insulin-like growth factor-1 deficiency.

PubMed lists PMID 36479333 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2022-12-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.

PubMed lists PMID 24463069 in Biochimica et biophysica acta as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2014-01-23 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

[A review: the role of antimicrobial peptide LL-37 in chronic sinusitis].

PubMed lists PMID 24738326 in Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery as Journal Article, Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

The Role of Cathelicidin LL-37 in Cancer Development.

PubMed lists PMID 26395996 in Archivum immunologiae et therapiae experimentalis as Journal Article, Review, with publication-date metadata of 2015-09-22 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Unique features of human cathelicidin LL-37.

PubMed lists PMID 26434733 in BioFactors (Oxford, England) as Journal Article, Review, with publication-date metadata of 2015-10-05 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.

PubMed lists PMID 27117377 in Pharmacological reports : PR as Journal Article, Review, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.

PubMed lists PMID 27135484 in Inflammatory bowel diseases as Journal Article, Review, with publication-date metadata of 2016-08 (month precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases.

PubMed lists PMID 28218580 in Clinical and investigative medicine. Medecine clinique et experimentale as Clinical Trial, Journal Article, with publication-date metadata of 2017-02-19 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Serum level of cathelicidin LL-37 in patients with active tuberculosis and other infectious diseases.

PubMed lists PMID 28956425 in Journal of biological regulators and homeostatic agents as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017 Jul-Sep (source-text precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.

PubMed lists PMID 29843147 in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology as Journal Article, Review, with publication-date metadata of 2018-05-25 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.

PubMed lists PMID 30980360 in Advances in experimental medicine and biology as Journal Article, Review, with publication-date metadata of 2019 (year precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report.

PubMed lists PMID 33275101 in Journal of investigational allergology & clinical immunology as Case Reports, Journal Article, with publication-date metadata of 2020-12-04 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.

PubMed lists PMID 34068993 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2021-05-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · MOTS-c

The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?

PubMed lists PMID 26289118 in Aging cell as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-08-20 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.

PubMed lists PMID 31987791 in Journal of the American Academy of Dermatology as Letter, Randomized Controlled Trial, with publication-date metadata of 2020-01-25 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

November 2022

21 records on this page

Literature metadata · Kisspeptin-10

Provocative tests with Kisspeptin-10 and GnRH set the scene for determining social status and environmental impacts on reproductive capacity in male African lions (Panthera leo).

PubMed lists PMID 36150474 in General and comparative endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-09-20 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT01143246

PeptideScanner retained ClinicalTrials.gov record NCT01143246 at 2026-11-15T21:47:40.408Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT02770716

PeptideScanner retained ClinicalTrials.gov record NCT02770716 at 2026-11-15T21:47:40.408Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Cagrilintide

PubMed record PMID 36242844

PeptideScanner retained PubMed bibliographic metadata for PMID 36242844 at 2026-07-30T19:34:05.168Z. PubMed recorded a metadata revision date of 2022-11-29 and an Entrez history date of 2022-10-15. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01796301

PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03479762

PeptideScanner retained ClinicalTrials.gov record NCT03479762 at 2026-07-30T19:32:59.846Z. Its registry update date was 2022-11-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Lutetium Lu 177 dotatate

Federal Register notice 2022-25549

The Federal Register published notice 2022-25549, attributed to FDA and its parent HHS department, on 2022-11-23. Its official title is “List of Bulk Drug Substances for Which There is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Lutetium Lu 177 dotatate.

Source: Federal Register via GovInfo ↗

→

Regulatory · Calcitonin salmon + 1 more

Federal Register notice 2022-25210

The Federal Register published notice 2022-25210, attributed to FDA and its parent HHS department, on 2022-11-18. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Calcitonin salmon and Goserelin.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05153590

PeptideScanner retained ClinicalTrials.gov record NCT05153590 at 2026-07-30T19:32:59.847Z. Its registry update date was 2022-11-17, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Desmopressin

Drugs@FDA application ANDA216922

The official Drugs@FDA dataset lists original submission 1 for ANDA 216922 with status AP dated 2022-11-16, and names desmopressin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT01568866

PeptideScanner retained ClinicalTrials.gov record NCT01568866 at 2026-11-16T17:39:29.005Z. Its registry update date was 2022-11-14, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04750460

PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT03590119

PeptideScanner retained ClinicalTrials.gov record NCT03590119 at 2026-11-16T01:36:36.861Z. Its registry update date was 2022-11-08, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Desmopressin

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis.

PubMed lists PMID 35192687 in Blood advances as Journal Article, Meta-Analysis, Systematic Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-06-28 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

October 2022

11 records on this page

Literature metadata · MK-677

Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren.

PubMed lists PMID 34737341 in Nature communications as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-11-04 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · MOTS-c

MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.

PubMed lists PMID 36233287 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2022-10-09 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios.

PubMed lists PMID 35353020 in Expert review of anti-infective therapy as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-04-08 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental development and preeclampsia.

PubMed lists PMID 36187484 in Frontiers in cell and developmental biology as Journal Article, Review, with publication-date metadata of 2022-09-14 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teduglutide

ClinicalTrials.gov record NCT04465396

PeptideScanner retained ClinicalTrials.gov record NCT04465396 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-10-04, and PeptideScanner's reviewed identity mapping was teduglutide.

Source: ClinicalTrials.gov ↗

→

September 2022

15 records on this page

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT00608023

PeptideScanner retained ClinicalTrials.gov record NCT00608023 at 2026-07-30T19:35:26.307Z. Its registry update date was 2022-09-30, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT03416374

PeptideScanner retained ClinicalTrials.gov record NCT03416374 at 2026-11-16T17:39:29.005Z. Its registry update date was 2022-09-27, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT02412878

PeptideScanner retained ClinicalTrials.gov record NCT02412878 at 2026-11-16T17:39:29.005Z. Its registry update date was 2022-09-23, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT01080391

PeptideScanner retained ClinicalTrials.gov record NCT01080391 at 2026-11-16T17:39:29.005Z. Its registry update date was 2022-09-21, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Dalbavancin

ClinicalTrials.gov record NCT04959799

PeptideScanner retained ClinicalTrials.gov record NCT04959799 at 2026-11-16T17:37:42.807Z. Its registry update date was 2022-09-21, and PeptideScanner's reviewed identity mapping was dalbavancin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dalbavancin

Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review.

PubMed lists PMID 34923922 in Journal of chemotherapy (Florence, Italy) as Journal Article, Review, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Terlipressin

Drugs@FDA application NDA022231

The official Drugs@FDA dataset lists original submission 1 for NDA 022231 with status AP dated 2022-09-14, and names terlipressin acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT05533008

PeptideScanner retained ClinicalTrials.gov record NCT05533008 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-09-08, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Dasiglucagon

ClinicalTrials.gov record NCT04764968

PeptideScanner retained ClinicalTrials.gov record NCT04764968 at 2026-11-16T01:42:39.027Z. Its registry update date was 2022-09-07, and PeptideScanner's reviewed identity mapping was dasiglucagon.

Source: ClinicalTrials.gov ↗

→

Regulatory · Vosoritide

Federal Register notice 2022-19155

The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Daptomycin

Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review.

PubMed lists PMID 31207214 in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases as Journal Article, Systematic Review, with publication-date metadata of 2019-06-14 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

August 2022

14 records on this page

Regulatory · Tirzepatide

Federal Register notice 2022-18523

The Federal Register published notice 2022-18523, attributed to FDA and its parent HHS department, on 2022-08-29. Its official title is “Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure Priority Review Voucher,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

Source: Federal Register via GovInfo ↗

→

Regulatory · Eptifibatide

Federal Register notice 2022-17056

The Federal Register published notice 2022-17056, attributed to FDA and its parent HHS department, on 2022-08-09. Its official title is “Determination That AVC (Sulfanilamide) Vaginal Cream, 15%, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Eptifibatide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Pramlintide

Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.

PubMed lists PMID 29389581 in Journal of food and drug analysis as Journal Article, with publication-date metadata of 2017-08-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Setmelanotide

Federal Register notice 2022-16502

The Federal Register published notice 2022-16502, attributed to FDA and its parent HHS department, on 2022-08-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Source: Federal Register via GovInfo ↗

→

July 2022

18 records on this page

Literature metadata · Dulaglutide

Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

The role of secretin in the cerebellum.

PubMed lists PMID 16527763 in Cerebellum (London, England) as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2006 (year precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Aviptadil

Anticipated pharmacological role of Aviptadil on COVID-19.

PubMed lists PMID 34846667 in Environmental science and pollution research international as Journal Article, Review, with publication-date metadata of 2021-11-30 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?

PubMed lists PMID 35493825 in Frontiers in neurology as Journal Article, Review, with publication-date metadata of 2022-04-15 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Preparation and characterization of an electrospun colon-specific delivery system for salmon calcitonin.

PubMed lists PMID 35540827 in RSC advances as Journal Article, with publication-date metadata of 2018-03-08 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Enfuvirtide biosynthesis in thermostable chaperone-based fusion.

PubMed lists PMID 35646620 in Biotechnology reports (Amsterdam, Netherlands) as Journal Article, with publication-date metadata of 2022-05-14 (day precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

Triptorelin embonate (6-month formulation).

PubMed lists PMID 20166771 in Drugs as Journal Article, Review, with publication-date metadata of 2010-02-12 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.

PubMed lists PMID 34787825 in CEN case reports as Case Reports, Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.

PubMed lists PMID 34934969 in European urology open science as Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Vancomycin, Daptomycin, Antistaphylococcal β-Lactam, and Trimethoprim-Sulfamethoxazole Monotherapy and Combination Therapy in the Management of Methicillin-Resistant Staphylococcus aureus: A Network…

PubMed lists PMID 35656305 in Frontiers in pharmacology as Systematic Review, Journal Article, with publication-date metadata of 2022-05-17 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-2

Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.

PubMed lists PMID 9798733 in Endocrine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.

PubMed lists PMID 35786589 in Biological & pharmaceutical bulletin as Journal Article, Meta-Analysis, with publication-date metadata of 2022 (year precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Setmelanotide

Federal Register notice 2022-14134

The Federal Register published notice 2022-14134, attributed to FDA and its parent HHS department, on 2022-07-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Source: Federal Register via GovInfo ↗

→

June 2022

16 records on this page

Literature metadata · Bremelanotide

The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.

PubMed lists PMID 33455598 in CNS spectrums as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective.

PubMed lists PMID 35234086 in Drug development and industrial pharmacy as Journal Article, with publication-date metadata of 2022-03-15 (day precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin in pediatric extracorporeal membrane oxygenation.

PubMed lists PMID 35634698 in Current opinion in pediatrics as Journal Article, Review, with publication-date metadata of 2022-06-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Plecanatide

Liquid-Phase Total Synthesis of Plecanatide Aided by Diphenylphosphinyloxyl Diphenyl Ketone (DDK) Derivatives.

PubMed lists PMID 32275447 in Organic letters as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-10 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

May 2022

15 records on this page

Literature metadata · Humanin

Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition.

PubMed lists PMID 35104624 in Biochimica et biophysica acta. General subjects as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2022-01-31 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Role of Bivalirudin for Anticoagulation in Adult Perioperative Cardiothoracic Practice.

PubMed lists PMID 31521492 in Journal of cardiothoracic and vascular anesthesia as Journal Article, Review, with publication-date metadata of 2019-08-21 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Exenatide + 1 more

Federal Register notice 2022-10701

The Federal Register published notice 2022-10701, attributed to FDA and its parent HHS department, on 2022-05-20. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Linaclotide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Eptifibatide

Acute intraprocedural thrombosis during an arterial ductal stenting successfully managed by eptifibatide.

PubMed lists PMID 34462026 in Cardiology in the young as Journal Article, with publication-date metadata of 2021-08-31 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Monosymptomatic Nocturnal Enuresis Treatment Using Alarm-Therapy and Desmopressin: A Meta-analysis Approach.

PubMed lists PMID 35169370 in Medical archives (Sarajevo, Bosnia and Herzegovina) as Journal Article, Meta-Analysis, with publication-date metadata of 2021-12 (month precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teduglutide

Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.

PubMed lists PMID 34903028 in Nutricion hospitalaria as Case Reports, Journal Article, with publication-date metadata of 2022-02-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

April 2022

24 records on this page

Literature metadata · Degarelix

Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands.

PubMed lists PMID 35069083 in Current urology as Journal Article, with publication-date metadata of 2021-06-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT03422653

PeptideScanner retained ClinicalTrials.gov record NCT03422653 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT03636269

PeptideScanner retained ClinicalTrials.gov record NCT03636269 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Terlipressin

RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY.

PubMed lists PMID 35442343 in Arquivos de gastroenterologia as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2022 Jan-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Lutetium Lu 177 dotatate

Lutetium Lu-177 Dotatate Flare Reaction.

PubMed lists PMID 33490736 in Advances in radiation oncology as Journal Article, with publication-date metadata of 2020-11-26 (day precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Desmopressin treatment for nocturia caused by nocturnal polyuria: practical guidelines.

PubMed lists PMID 33552576 in Central European journal of urology as Journal Article, Review, with publication-date metadata of 2020-11-02 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

Humanin and diabetes mellitus: A review of in vitro and in vivo studies.

PubMed lists PMID 35432758 in World journal of diabetes as Journal Article, Review, with publication-date metadata of 2022-03-15 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

How satisfactory is on-demand icatibant from the patients' perspective in real life?

PubMed lists PMID 35317892 in Allergy and asthma proceedings as Journal Article, with publication-date metadata of 2022-03-01 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Eptifibatide

Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.

PubMed lists PMID 28959324 in Iranian journal of biotechnology as Journal Article, with publication-date metadata of 2016-06 (month precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.

PubMed lists PMID 22989378 in BMC neurology as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2012-09-18 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.

PubMed lists PMID 23795716 in Expert opinion on drug metabolism & toxicology as Journal Article, Review, with publication-date metadata of 2013-06-25 (day precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to Metreleptin.

PubMed lists PMID 30923630 in Clinical diabetes and endocrinology as Case Reports, Journal Article, with publication-date metadata of 2019-03-14 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Plecanatide

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.

PubMed lists PMID 28169285 in The American journal of gastroenterology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-02-07 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration.

PubMed lists PMID 35372353 in Frontiers in cell and developmental biology as Journal Article, Review, with publication-date metadata of 2022-03-16 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT01578239

PeptideScanner retained ClinicalTrials.gov record NCT01578239 at 2026-11-16T01:36:36.861Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT03973047

PeptideScanner retained ClinicalTrials.gov record NCT03973047 at 2026-07-30T19:40:58.916Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was bremelanotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Motixafortide

Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial.

PubMed lists PMID 34253578 in Clinical cancer research : an official journal of the American Association for Cancer Research as Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-07-12 (day precision). PeptideScanner associated the retained record with the identity slug motixafortide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.

PubMed lists PMID 35007937 in Thrombosis research as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2021-12-31 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00754442

PeptideScanner retained ClinicalTrials.gov record NCT00754442 at 2026-07-30T19:40:58.915Z. Its registry update date was 2022-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

March 2022

39 records on this page

Literature metadata · Cerebrolysin

Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.

PubMed lists PMID 11738849 in Brain & development as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Mecasermin

Mecasermin.

PubMed lists PMID 18481900 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2008 (year precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. French study group of Decapeptyl in…

PubMed lists PMID 10372696 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, with publication-date metadata of 1999-06 (month precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Goserelin

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

PubMed lists PMID 14679153 in Journal of the National Cancer Institute as Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, and 1 more PubMed publication type, with publication-date metadata of 2003-12-17 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Goserelin

Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.

PubMed lists PMID 20679610 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-08-02 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glatiramer acetate

Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.

PubMed lists PMID 26458034 in JAMA neurology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-12 (month precision). PeptideScanner associated the retained record with the identity slug glatiramer-acetate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

PubMed lists PMID 22970904 in Expert opinion on pharmacotherapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2012-09-13 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury.

PubMed lists PMID 32737904 in Hepatology (Baltimore, Md.) as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2020-11-19 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT03500549

PeptideScanner retained ClinicalTrials.gov record NCT03500549 at 2026-11-16T01:37:14.654Z. Its registry update date was 2022-03-25, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT03795558

PeptideScanner retained ClinicalTrials.gov record NCT03795558 at 2026-11-15T22:07:29.454Z. Its registry update date was 2022-03-23, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT05288465

PeptideScanner retained ClinicalTrials.gov record NCT05288465 at 2026-11-16T17:33:14.861Z. Its registry update date was 2022-03-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · GHRP-2

Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.

PubMed lists PMID 20045717 in Peptides as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01-05 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-2

Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.

PubMed lists PMID 27020037 in Endocrine journal as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2016-03-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

Pramlintide and the treatment of diabetes: a review of the data since its introduction.

PubMed lists PMID 21564002 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2011-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test.

PubMed lists PMID 27443694 in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis as Journal Article, Review, with publication-date metadata of 2016-07-21 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Larazotide

Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series.

PubMed lists PMID 35211683 in Critical care explorations as Journal Article, with publication-date metadata of 2022-02-18 (day precision). PeptideScanner associated the retained record with the identity slug larazotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Goserelin

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer.

PubMed lists PMID 16222310 in British journal of cancer as Clinical Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2005-09-19 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin alpha-1

From lab to bedside: emerging clinical applications of thymosin alpha 1.

PubMed lists PMID 19392576 in Expert opinion on biological therapy as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2009-05 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.

PubMed lists PMID 24169554 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-12-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

Vosoritide.

PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

PubMed lists PMID 20463350 in The New England journal of medicine as Clinical Trial, Letter, Multicenter Study, with publication-date metadata of 2010-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bremelanotide

Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

The emerging role of the mitochondrial-derived peptide humanin in stress resistance.

PubMed lists PMID 23239898 in Journal of molecular endocrinology as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-01-11 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

Humanin: Functional Interfaces with IGF-I.

PubMed lists PMID 27082450 in Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society as Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-04-07 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Everolimus and pasireotide for advanced and metastatic hepatocellular carcinoma.

PubMed lists PMID 25613083 in Investigational new drugs as Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2015-01-23 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.

PubMed lists PMID 29264358 in Research and reports in urology as Journal Article, with publication-date metadata of 2017-12-06 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Kisspeptin-10

Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.

PubMed lists PMID 29264460 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2017-10-16 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Mecasermin

Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.

PubMed lists PMID 19707272 in Therapeutics and clinical risk management as Journal Article, with publication-date metadata of 2009-08-03 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Pasireotide for the treatment of acromegaly.

PubMed lists PMID 26808354 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2016-02-17 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

PubMed lists PMID 11238504 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2001-03 (month precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.

PubMed lists PMID 9801989 in Journal of endocrinological investigation as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-09 (month precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Goserelin

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.

PubMed lists PMID 14760369 in British journal of cancer as Clinical Trial, Journal Article, with publication-date metadata of 2004-02-09 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

PubMed lists PMID 18957506 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Phase II, Journal Article, Multicenter Study, with publication-date metadata of 2008-10-28 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Goserelin

Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.

PubMed lists PMID 22972694 in Cancer as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-09-12 (day precision). PeptideScanner associated the retained record with the identity slug goserelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.

PubMed lists PMID 24287689 in Pituitary as Case Reports, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-12 (month precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

Abaloparatide: a new anabolic therapy on the horizon.

PubMed lists PMID 25987981 in BoneKEy reports as Journal Article, with publication-date metadata of 2015-04-29 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT03201419

PeptideScanner retained ClinicalTrials.gov record NCT03201419 at 2026-11-16T01:33:21.554Z. Its registry update date was 2022-03-02, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

February 2022

2 records on this page

Clinical trials · Calcitonin salmon

ClinicalTrials.gov record NCT03342001

PeptideScanner retained ClinicalTrials.gov record NCT03342001 at 2026-11-15T21:54:02.201Z. Its registry update date was 2022-02-21, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.

Source: ClinicalTrials.gov ↗

→

Regulatory · Leuprolide

Federal Register notice 2022-03248

The Federal Register published notice 2022-03248, attributed to FDA and its parent HHS department, on 2022-02-18. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→